Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LAPTM4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GPLD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC39A14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YES1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GTF2A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SKP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EID1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF132 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HAUS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SVIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929356 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCBP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TXNDC16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC36A4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARPBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDE1C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRMT6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LMNB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on